Why I asked myself. From SEC fillings I learned a Sarissa Capital had purchased $11 million dollars of shares @ $.88. Having been burnt once I looked up Sarissa. The guy that runs it spent 6 years as senior director for Carl Ican before leaving to form Sarissa Capital in 2012.
The company has a couple of drugs in Phase 11 clinical trials. Sarissa Capital seems like a legitimate firm but I am just going to observe for now. I have alerts set at $1.10 and $1.50.
On Monday I was looking at some oil stocks and found PVA a stock that was trading at $8 last summer but was down to $.20cents. A little probing revealed that George Soros had acquired 6 million shares the Friday before. The company is producing but is carrying a ton of debt but I couldn't understand why Soros might be involved. PVA is listed on the NYSE so I thought possibly the company trying a last ditch effort to keep their listing.
Tuesday they halted trading and unlisted the stock and it is now selling at $.05cents. Anybody have any idea what Soros might be looking at doing.
And is Sarissa betting the clincial trials are going to be approved?
I love doing research and bargain hunting but right now it seems all I can do is watch. Anyone have any suggestions what to watch for. Or where I can dig deeper?
This entry passed through the Full-Text RSS service - if this is your content and you're reading it on someone else's site, please read the FAQ at http://ift.tt/jcXqJW.
Anatomy of a Stock
Aucun commentaire:
Enregistrer un commentaire